PRECISION BIOSCIENCES INC
DTIL·74019P207·US·Common Stock·Healthcare - Biotechnology-13D/G
DTIL (PRECISION BIOSCIENCES INC) is held by 51 institutional investors as of Q1 2026. Largest holders: Aberdeen Group plc ($12.3M), DRIEHAUS CAPITAL MANAGEMENT LLC ($5.5M), VANGUARD CAPITAL MANAGEMENT LLC ($5M). Net institutional sentiment: Bullish.
51
Holders
Avg rating(11 Elite)
$38.7M
Total Value
71% (56)
Fund Consensus
34 buying - 14 selling
Who's Trading
ActivistEAEmpery Asset Management, LP7.6%Apr 15, 2026
InsiderAMAmoroso MichaelSell $79KFeb 18, 2026
InsiderKAKelly John AlexanderSell $31KFeb 18, 2026
InsiderSJSMITH J. JEFFERSONSell $19KFeb 18, 2026
InsiderSDScimeca DarioSell $19KFeb 18, 2026
ActivistTATANG CAPITAL MANAGEMENT, LLC0.0%Feb 17, 2026
ActivistLYLynx1 Capital Management LP4.1%Feb 17, 2026
ActivistBLBleichroeder LP8.2%Feb 13, 2026
ActivistOAOctagon Capital Advisors LP10.0%Feb 10, 2026
13F: Insider & Congress:
Showing 1-20 of 56
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer